Clinical Education InitiativeMenu
Search
Home > Courses > Advances in Testing for HIV and HCV

Advances in Testing for HIV and HCV

Advances in Testing for HIV and HCV
Play
Sorry, this learning module is not available for mobile devices.
Original Presentation: 8/11/2015
Web Posting: 11/10/2015
CE Expiration: 08/11/2018
Presenter
  • Bernard M. Branson, MD
    Associate Director for Laboratory Diagnostics
    Centers for Disease Control and Prevention, Atlanta, GA
Learning Objectives
At the completion of this educational session, participants will:
  1. Compare the relative sensitivity of FDA-approved HIV tests during seroconversion.
  2. Describe the recommended sequence of tests for the diagnosis of HIV and active HCV infections.
  3. Appreciate the benefits of screening for undiagnosed HIV and HCV infections and for acute HIV infection.
  4. Interpret results of HIV tests that have recently received FDA approval and describe new tests on the horizon.
Presenter Bio
Bernard Branson, MD
Bernard Branson is currently Associate Director for Laboratory Diagnostics in the Division of HIV/AIDS Prevention in the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention at the CDC. Dr. Branson has been the chief architect for CDC’s activities surrounding new technologies for HIV testing, including rapid HIV tests and tests for HIV incidence. He was lead author for CDC’s 2006 Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health Care Settings. Most recently Dr. Branson conceived and coordinated validation of the new diagnostic algorithm for laboratory testing to establish the diagnosis of HIV. Dr. Branson has been involved in HIV testing for more than 25 years, and authored more than 50 peer-reviewed articles on HIV diagnostics, HIV screening, and cost-effectiveness. Before joining CDC in 1990, Dr. Branson was in private practice and clinical faculty at the Johns Hopkins Medical Institutions.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on August 11, 2015 and will terminate August, 2018.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose. 
  • Dr. Branson (Presenter) had the following personal financial relationships in the previous 12 months with manufacturers of the products or services that may be presented in this CME activity: Consulting fee from Cepheid, and Chembio Diagnostics. Dr. Branson submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

PRN Learning Modules